April 2023
165 articles-
Apr 28 · 01:33Biotechnology Daily
Mysterious biotech makes last-minute bid to snatch Jounce out of Redx's hands
-
Apr 28 · 01:31Biotechnology Daily
The delisting dilemma: Why do so many biotechs face being kicked off the Nasdaq?
-
Apr 28 · 01:29Biotechnology Daily
Philips finds new head of recall-laden connected care segment in Pear Therapeutics exec
-
Apr 28 · 01:28Biotechnology Daily
Bellicum's GoCAR-Ts crash out of clinic over safety signal, sparking search for strategic alternatives
-
Apr 28 · 01:27Bio Business News
PerkinElmer completes $2.45B spinoff to create new diagnostics, life sciences company
-
Apr 28 · 01:25Bio Business News
Synaffix, MacroGenics crack open ADC pact, tacking on $2.2B, 4 more programs
-
Apr 28 · 01:24Bio Business News
Servier serves up phase 3 brain tumor win at interim analysis, validating $1.8B buyout of Agios unit
-
Apr 28 · 01:23Bio Business News
Armed with $105M and Big Pharma backing, Mediar takes aim at fibrotic mediators
-
Apr 27 · 03:19Biotechnology Daily
2-protein knockout helps T-cell therapies hit harder
-
Apr 27 · 03:17Biotechnology Daily
After rejection and appeal, Omeros saddles up for 2nd charge at transplant drug approval
-
Apr 27 · 03:16Biotechnology Daily
Heart tissue on a chip is headed back up to the International Space Station
-
Apr 27 · 03:14Biotechnology Daily
Acesion, targeting first new approach to afib in decades, hits primary endpoint in midphase trial
-
Apr 27 · 03:13Bio Business News
Insulet tapped to replace SVB on S&P 500 index after bank collapse
-
Apr 27 · 03:11Bio Business News
Illumina facing proxy battle led by activist investor Carl Icahn over Grail acquisition: WSJ
-
Apr 27 · 03:09Bio Business News
Biden says America's 'banking system is safe' after regulators back up all SVB deposits
-
Apr 27 · 03:08Bio Business News
GSK's $100M ADC bet in doubt after fatality in first trial of Mersana's cancer therapy
-
Apr 26 · 04:00Biotechnology Daily
A 'magic whistle': Hands-free version of COPD breath tech improves airflow, study finds
-
Apr 26 · 03:59Biotechnology Daily
Female mouse behavior more stable than males' despite hormone fluxes, challenging prevailing dogma in neuroscience research
-
Apr 26 · 03:58Biotechnology Daily
Vyne swings behind BET inhibitors, seeks partner for failed eczema drug
-
Apr 26 · 03:57Biotechnology Daily
FDA finds at least 19 cases of skin cancer in breast implant data, including 3 deaths
-
Apr 26 · 03:56Bio Business News
UK biopharma body praises bank for keeping doors open at life science startups by rescuing SVB UK
-
Apr 26 · 03:54Bio Business News
After slimming down, Applied Molecular Transport no closer to taking UC drug into phase 3
-
Apr 26 · 03:53Bio Business News
FDA's first 'safer technologies' nod goes to Endolumik's glowing tube to guide weight-loss surgeries
-
Apr 26 · 03:52Bio Business News
Olema, prioritizing oral SERD, plans 25% head count cut, pulls back from early-stage work